April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Notch Signaling: A New Potential Target in the Treatment of Uveal Melanoma
L. Asnaghi; M. L. Coonfield; K. C. Schreck; E. E. Bar; J. Handa; S. Merbs; K. Ebrahimi; J. Harbour; C. G. Eberhart
Author Affiliations & Notes
  • L. Asnaghi
    Dept. of Pathology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • M. L. Coonfield
    Dept. of Pathology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • K. C. Schreck
    Dept. of Pathology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • E. E. Bar
    Dept. of Pathology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • J. Handa
    Dept. of Ophthalmology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • S. Merbs
    Dept. of Ophthalmology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • K. Ebrahimi
    Dept. of Ophthalmology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • J. Harbour
    Dept. of Ophthalmology & Visual Sciences, School of Medicine, Washington University, St Louis, Missouri
  • C. G. Eberhart
    Dept. of Pathology, Dept. of Ophthalmology, School of Medicine,
    Johns Hopkins University, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  L. Asnaghi, None; M.L. Coonfield, None; K.C. Schreck, None; E.E. Bar, None; J. Handa, None; S. Merbs, None; K. Ebrahimi, None; J. Harbour, None; C.G. Eberhart, None.
  • Footnotes
    Support  Witener and Roten Funds; Research to Prevent Blindness; Linda Moriarty and the Community Foundation of Western Massachussetts.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3803. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Notch Signaling: A New Potential Target in the Treatment of Uveal Melanoma
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      L. Asnaghi, M. L. Coonfield, K. C. Schreck, E. E. Bar, J. Handa, S. Merbs, K. Ebrahimi, J. Harbour, C. G. Eberhart; Notch Signaling: A New Potential Target in the Treatment of Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3803.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To investigate the role of Notch signaling in promoting uveal melanoma cellular proliferation and invasion.

Methods: : Growth, invasion and clonogenicity of cell lines were examined using MTT, transwell migration and soft agar assays. Expression of Notch pathway member mRNA and protein was measured using qPCR and Western blotting.

Results: : We examined five established uveal melanoma cell lines, and found using qPCR that the Notch 1-2-3 receptors, Jag1-2 ligands and the pathway target Hes1 were expressed to varying degrees in all lines. We then blocked Notch signaling using a gamma-secretase inhibitor (GSI), and found that only three of the lines (OCM1, OCM3, OCM8) had their growth inhibited by the drug. Interestingly, these three lines had significantly higher levels of Hes1 mRNA as compared to the two lines resistant to GSI treatment (Mel285, Mel290). GSI treatment induced a dose-dependent reduction of anchorage-independent clonogenic growth, with 50% inhibition in OCM1, 70% in OCM3, and 40% in OCM8, as well as a significant reduction in Hes1 mRNA and protein levels. Apoptosis, as measured by cleavage and activation of caspase-9, was also induced. Finally, we observed inhibition of cellular invasion in GSI treated cultures using transwell assays. Preliminary studies of snap-frozen primary tumors indicate that Notch pathway components are expressed in uveal melanoma in vivo as well. In addition, oligonucleotide microarray analysis showed a significant increase in Jag2 and Notch3 expression levels in primary uveal melanomas that metastasized as compared to those that did not.

Conclusions: : Our findings suggest that the Notch pathway plays an important role in inducing cellular proliferation and invasion in uveal melanoma, and that inhibiting this pathway using pharmacological agents may be effective in preventing tumor growth and metastasis.

Keywords: uvea • melanoma • cell survival 
© 2010, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept